Adonis Stassinopoulos
14Patents
6h-index
22Co-inventors
66Inventor score
Filing activity: Jan 6, 1998 → Aug 25, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6270952A | Methods for quenching pathogen inactivators in biological materials | Human Necessities | 39 | Expired |
| US6093725A | Frangible compounds for pathogen inactivation | Chemistry; Metallurgy | 36 | Expired |
| US6514987B1 | Frangible compounds for pathogen inactivation | Chemistry; Metallurgy | 28 | Expired |
| US6709810B2 | Methods for quenching pathogen inactivators in biological materials | Human Necessities | 26 | Expired |
| US7293985B2 | Methods for quenching pathogen inactivators in biological materials | Human Necessities | 20 | Expired |
| US7655392B2 | Quenching methods for red blood cell inactivation process | Human Necessities | 19 | Active |
| US11554185B2 | Systems and methods for treating biological fluids | Human Necessities | 3 | Active |
| US11783563B2 | Software and algorithms for use in remote assessment of disease diagnostics | Emerging Cross-Sectional Technologies | 1 | Active |
| US6395904B1 | Binuclear non-heme iron catalysts | Chemistry; Metallurgy | 1 | Expired |
| US12298251B2 | System and methods for remote assessment of a sample assay for disease diagnostics | Physics | 0 | Active |
| US12055542B2 | System and methods for remote assessment of a sample assay for disease diagnostics | Physics | 0 | Active |
| US10688166B2 | Compositions and methods for improved car-T cell therapies | Chemistry; Metallurgy | 0 | Active |
| US12214092B2 | Systems and methods for treating biological fluids | Human Necessities | 0 | Active |
| US12165373B2 | Software and algorithms for use in remote assessment of disease diagnostics | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.